LENZ Therapeutics Inc (LENZ) PT Lowered to $35 at BofA Securities
Tweet Send to a Friend
BofA Securities analyst Jason Gerberry lowered the price target on LENZ Therapeutics Inc (NASDAQ: LENZ) to $35.00 (from $52.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
